← All trials
NCT00598897
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 1995
- Primary completion
- Aug 7, 2002
- Completion date
- May 18, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 89
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- University of Texas, TylerLead sponsor
- University of Texas, TylerOverall official - principal investigator
- AbbottCollaborator
- PfizerCollaborator
- University of Texas, TylerReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.